Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares (ZEPP) is a publicly traded Technology sector company. As of May 21, 2026, ZEPP trades at $8.81 with a market cap of $156.48M and a P/E ratio of 0.00. ZEPP moved -5.10% today. Year to date, ZEPP is -70.24%; over the trailing twelve months it is +231.20%. Its 52-week range spans $2.13 to $61.85. Analyst consensus is buy with an average price target of $56.28. Rallies surfaces ZEPP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own ZEPP include Mangrove Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares.
| Metric | Value |
|---|---|
| Price | $8.81 |
| Market Cap | $156.48M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.10% |
| 52-Week High | $61.85 |
| 52-Week Low | $2.13 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover ZEPP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $56.28.